Common Data Quality Challenges in Pharma MDM (and How to Fix Them)

In pharmaceutical organizations, Master Data Management (MDM) sits at the center of analytics, commercial operations, regulatory reporting, and patient engagement. Yet even the most advanced MDM platforms fail to deliver value when underlying data quality is weak.

Poor quality master data doesn’t just create technical debt it leads to fragmented HCP views, unreliable dashboards, duplicated outreach, compliance risk, and misguided business decisions. In regulated environments overseen by bodies such as U.S. Food and Drug Administration and European Medicines Agency, inaccurate or inconsistent master data can also introduce operational and regulatory exposure.

Let’s walk through the most common data quality challenges in Pharma MDM and practical ways to resolve them.

1. How to Design a Data Quality Dashboard (Duplicates, Completeness & Survivorship Conflicts)

A data quality dashboard should act as your operational control tower for MDM. Its purpose isn’t just visualization it’s early detection of degradation in your golden records. In pharma, where HCP/HCO accuracy directly impacts sales alignment, patient programs, and compliance, your dashboard must continuously surface duplication trends, attribute gaps, and survivorship disagreements.

The most effective dashboards separate overall health metrics from actionable exception views, allowing both leadership and data stewards to operate from the same source of truth.

Executive Summary (Top Layer)

• Total master records
• Duplicate rate (%)
• Attribute completeness (%)
• Open stewardship cases
• Weekly trend indicators

This gives management instant visibility.

Duplicate Monitoring

Track matching performance over time:

• Total clusters created
• Records merged per day/week
• Duplicate percentage by entity (HCP, HCO, Product)
• New duplicates introduced from each source
• High risk clusters (borderline match scores)

Helpful measures:

• Duplicate Rate = Duplicates / Total Records
• Average Cluster Size
• Match Confidence Distribution

Attribute Completeness

Measure field level quality:

• % populated for specialty, license ID, address, affiliation
• Completeness by source system
• Completeness by geography
• Golden vs raw completeness comparison

Flag fields critical for downstream analytics.

Survivorship Conflicts

Surface where sources disagree:

• Count of attributes overridden by survivorship
• Top conflicting fields (address, specialty, email)
• Source vs source conflict frequency
• Manual steward overrides

This tells you whether survivorship logic needs tuning.

Stewardship Operations

Track workload and efficiency:

• Open vs closed cases
• Average resolution time
• Backlog aging
• Cases by type (duplicate / missing data / conflicts)

Practical Tip

Always design dashboards around decision paths, not visuals.

Every chart should answer: What action does this trigger?

2. How to Explain Matching Thresholds & Survivorship Logic to Business Stakeholders

Business teams don’t care about probabilistic algorithms they care about trust. Your job is to translate matching and survivorship into business outcomes, not technical mechanics. Instead of describing scores and weights, frame everything around confidence, accuracy, and impact.

Use real scenarios and avoid algorithmic language.

Explaining Matching Thresholds

Instead of: “We use probabilistic matching with 85% thresholds.”

Say: “If two profiles are at least 85% similar across name, address, and identifiers, we treat them as the same HCP.”

Then explain outcomes:

Three Matching Zones

• Auto-Merge Zone (High confidence)
  • System merges automatically
  • Minimal risk
• Review Zone (Medium confidence)
  • Human steward validates
• No Match Zone (Low confidence)
  • Records stay separate

Business Translation

• Higher threshold = fewer wrong merges, more manual work
• Lower threshold = faster automation, higher merge risk

It’s always a balance between accuracy and efficiency.

Explaining Survivorship

Describe survivorship as field ownership.

Example explanation: “Address comes from CRM because sales updates it. Specialty comes from vendor data because it’s certified. License ID comes from regulatory feeds.”

Then summarize:

Survivorship Principles

• Each attribute has a trusted source
• Recency applies when multiple trusted sources exist
• Completeness breaks ties
• Manual override is last resort

Visual Storytelling Helps

Show:

• Raw sources → Golden record
• Highlight which field came from where

Business stakeholders understand visually in seconds.

3. How to Operationalize Stewardship at Scale

Stewardship fails when it’s reactive and manual. It succeeds when it’s structured, metric driven, and embedded into daily workflows. In growing pharma MDM programs, stewardship must behave like a production process with queues, SLAs, ownership, and performance tracking.

Think of stewards as data operators, not cleaners.

Build a Tiered Stewardship Model

Level 1 : Automated Resolution

Handled by system rules:

• High confidence matches
• Clear survivorship decisions
• Standard validations

Goal: 70–80% automated.

Level 2 : Business Steward Review

Handled by domain experts:

• Borderline matches
• Specialty conflicts
• Affiliation discrepancies

Goal: fast turnaround with clear SOPs.

Level 3 : Data Governance Escalation

Handled by governance leads:

• Policy changes
• Source priority disputes
• Rule modifications

Rare but critical.

Create Structured Queues

Instead of one big inbox:

• Duplicate review queue
• Missing data queue
• Survivorship conflict queue

Each queue should have:

• Priority level
• SLA
• Owner
• Resolution status

Track Stewardship KPIs

Measure:

• Average resolution time
• Daily case throughput
• Reopen rate
• Backlog age
• Overrides per steward

What gets measured improves.

Automate Feedback Loops

• Frequent conflicts → adjust survivorship rules
• Repeated duplicates → tune matching thresholds
• Missing fields → update validation logic

Stewardship should continuously improve the system.

4. Conflicting Attribute Values Across Sources

Conflicting attributes are inevitable in Pharma MDM because the same entity is maintained across CRM, claims systems, third party vendors, regulatory feeds, and internal applications. Each source captures data for a different business purpose sales focuses on addresses, vendors on specialty, compliance on licenses. Without deliberate survivorship logic, MDM simply aggregates contradictions instead of resolving them.

This is where many programs quietly fail: records are matched correctly, but golden profiles remain unreliable because attribute conflicts are never systematically resolved. The result is “technically mastered” data that business teams still don’t trust.

True mastery happens when survivorship is applied at the field level, not just at the record level.

Typical Conflict Scenarios

• Different specialties from CRM vs vendor feeds
• Multiple addresses from sales vs claims
• License ID present in regulatory feed but missing internally
• Email or phone updated in one system only

These conflicts directly affect segmentation, targeting, analytics, and compliance.

How to Fix It (Practically)

Implement Attribute Level Survivorship

Instead of choosing one winning record, decide field by field:

• Address → CRM
• Specialty → Vendor feed
• License ID → Regulatory source
• Email → Most recent update

Create a survivorship matrix like:

Attribute	Primary Source	Secondary	Tie Breaker
Address	CRM	Claims	Most recent
Specialty	Vendor	CRM	Completeness
License	Regulatory	N/A	N/A

Apply Clear Rule Hierarchies

Use combinations of:

• Source trust ranking
• Recency
• Completeness
• Confidence score

Example logic:

1. Trusted source wins
2. If equal → most recent
3. If equal → most complete

This removes ambiguity.

Track Conflict Frequency

Measure:

• Top conflicting attributes
• Most disagreeing sources
• % attributes overridden by survivorship
• Manual overrides by field

Frequent conflicts usually signal upstream data problems.

Surface Conflicts to Stewards

Create dashboards or queues for:

• High impact conflicts (specialty, license)
• Repeated disagreements
• Manual override candidates

Survivorship should be auditable, explainable, and adjustable.

5. Weak Governance and Stewardship Processes

Many Pharma MDM initiatives invest heavily in matching engines and pipelines but underestimate governance. Without ownership, workflows, and accountability, data quality improvements decay rapidly. Stewardship becomes reactive firefighting, rules drift, and business users lose confidence.

MDM is not a one time integration it is an operating model. Governance defines who owns what, stewardship defines who fixes what, and metrics define whether it’s working.

When governance is weak, even technically strong MDM platforms collapse under manual overrides and inconsistent decisions.

Common Governance Gaps

• No clear data owners per entity or attribute
• Manual edits without audit trails
• No stewardship SLAs
• No quality KPIs
• Business teams bypassing MDM

How to Fix It (Operational Model)

Define Ownership Clearly

Assign:

• HCP Owner
• HCO Owner
• Product Owner

Each owner approves rule changes and quality standards.

Formalize Stewardship Workflows

Create structured processes:

• Duplicate review flow
• Missing data resolution
• Survivorship conflict handling
• Escalation paths

Every case should have:

• Priority
• SLA
• Assigned steward
• Status

Track Governance KPIs

At minimum:

• Duplicate rate
• Attribute completeness
• Open stewardship cases
• Average resolution time
• Override frequency

Governance without metrics is opinion based.

Maintain Change History

Log:

• Rule changes
• Manual merges
• Attribute overrides

This creates transparency and auditability.

Align Business Teams

Sales, analytics, and operations must understand:

• Why MDM rules exist
• How to request changes
• How quality impacts their outcomes

Governance succeeds through alignment, not enforcement.

6. Lack of Continuous Monitoring

One of the most dangerous assumptions in MDM is that data quality remains stable after go live. In reality, new sources onboard, vendors change formats, and operational systems evolve. Without continuous monitoring, quality slowly degrades until dashboards become unreliable and trust is lost.

High performing MDM programs treat monitoring like observability in production systems always on, automated, and proactive.

Data quality is not a milestone. It’s a lifecycle.

Typical Symptoms of Poor Monitoring

• Duplicate rate quietly increases
• Key attributes drift toward null
• Survivorship conflicts spike unnoticed
• Stewardship backlog grows
• Business users report issues before IT sees them

How to Fix It (Continuous Control)

Automate Quality Checks

Run daily or weekly validations for:

• Duplicate percentage
• Null rate per critical field
• Match confidence distribution
• Survivorship override volume

Trigger alerts when thresholds break.

Implement Trend Analysis

Track over time:

• Completeness by attribute
• Duplicate clusters per source
• Conflict frequency
• Stewardship throughput

Trends matter more than snapshots.

Set Quality Thresholds

Examples:

• Duplicate rate > 3% → alert
• Specialty completeness < 90% → alert
• Open cases > 100 → alert

Make degradation visible immediately.

Review Weekly with Stewards

Short operational review:

• New duplicates
• Top missing fields
• Rule adjustments needed
• Backlog health

Small weekly corrections prevent large failures.

Final Thoughts

Data quality in Pharma MDM isn’t a technical afterthought it’s the foundation of everything that follows: trusted HCP profiles, accurate analytics, compliant operations, and meaningful business decisions.

Duplicates, missing attributes, conflicting values, weak governance, and lack of monitoring are not isolated problems. They are interconnected signals of maturity. Solving them requires more than better matching algorithms or survivorship rules it demands an operational mindset where data quality is treated as a continuous discipline.

The most successful MDM programs do three things consistently:

• They design survivorship deliberately, at the attribute level
• They operationalize stewardship with ownership, SLAs, and measurable KPIs
• They monitor quality continuously, just like any production system

When these elements come together, MDM stops being a backend integration project and becomes a strategic data platform powering analytics, improving commercial alignment, strengthening compliance, and ultimately enabling better outcomes across the pharma value chain.